Live tape
Top 8, mentions 7d10,771GOOGL2,061 mentions▲ +0.04SNDK1,523 mentions▲ +0.11SPCX1,494 mentions▲ +0.08NBIS1,420 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,187 mentions▲ +0.08META1,015 mentions▲ +0.03MSFT839 mentions▲ +0.06

Equity · Healthcare

CELC

Celcuity Inc. · NasdaqCM

$92.53 +0.63% 1D Finazon · prior-day close · Aug 17, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$160 $80 20 May 17 Aug

The line runs $140 on 20 May through $92.53 on 17 August, on a scale from $80 to $160. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CELC over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $140 on 20 May 2026 through $92.53 on 17 August 2026.

Market cap $4.5B
52-week range $45 – $145
Avg volume 306.1K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

CELC insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 5 Jun 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 7

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
05 Jun 2026 Buller Richard E Director Award 1,530
05 Jun 2026 NIGON RICHARD Director Award 1,530
05 Jun 2026 Dalvey David Director Award 1,530
05 Jun 2026 Furcht Leo Director Award 1,530
05 Jun 2026 ROMP CHARLES R Director Award 1,530
05 Jun 2026 Murphy Polly A. Director Award 1,530
02 Jun 2026 Laing Lance G. Chief Science Officer Option exercise 1,000 $10K

CELC reported financials

SEC EDGAR XBRL

CELC reported net income of −$177.0M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$177.0M 31 Dec 2025 fiscal year
Diluted EPS −$3.79 31 Dec 2025 fiscal year
Total assets $828.2M 30 Jun 2026 at period end
Total equity −$12.8M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CELC earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-1.44 —
31 Mar 2026 Q1 2026 $-0.97 —
31 Dec 2025 FY 2025 $-3.79 —
30 Sep 2025 Q3 2025 $-0.92 —
30 Jun 2025 Q2 2025 $-1.04 —
31 Mar 2025 Q1 2025 $-0.86 —
31 Dec 2024 FY 2024 $-2.83 —
30 Sep 2024 Q3 2024 $-0.70 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CELC institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a CELC position for the quarter ended 30 Jun 2026 — a combined $929.1M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 7,915,792 $828.2M
Point72 Asset Management Added +132.2% shares 650,916 $68.1M
Marshall Wace Added +863.8% shares 182,156 $19.1M
Balyasny Asset Management Held (±25%) −10.4% shares 57,698 $6.0M
D. E. Shaw & Co. Added +46.7% shares 30,394 $3.2M
Man Group Trimmed −34.7% shares 28,845 $3.0M
AQR Capital Management Trimmed −29.2% shares 12,542 $1.3M
Fisher Asset Management New position 2,000 $209K
Citadel Advisors Exited
Millennium Management Exited

Source: SEC EDGAR 13F filings

CELC fails-to-deliver

SEC CNS data

On 30 Jul 2026, 48,400 shares of CELC failed to deliver (about $4.0M).

Settlement date Shares failed Notional % of shares out
30 Jul 2026 48,400 $4.0M 0.099%
28 Jul 2026 72,692 $6.0M 0.149%
22 Jul 2026 713 $65K 0.001%
21 Jul 2026 1 $88 <0.001%
16 Jul 2026 32,189 $2.9M 0.066%
15 Jul 2026 14,867 $1.7M 0.030%
10 Jul 2026 7,484 $850K 0.015%
09 Jul 2026 200 $22K <0.001%
08 Jul 2026 200 $23K <0.001%
06 Jul 2026 7,907 $854K 0.016%

Source: SEC fails-to-deliver (CNS) data